No Data
No Data
At a Glance: March's Hottest IPOs - Shangmi Technology Approved! Four New Stocks, Including ZhaoWei Electromechanical and EastControl, Undergoing Enthusiastic Subscription.
Hello, fellow investors! The New Stock Observer is here to provide updates on the popular HK IPOs in March and throughout 2026. Fellow investors, check it out now!
Maxin Health's IPO in Hong Kong: Breaking New Ground in the Medical Payment Sector and Long-Term Value
Crossing the river by feeling the stones. Cai Jun from The Investor reported that, after undergoing industry reshuffling and a return to capital rationality, the healthcare sector in Hong Kong's stock market has long bid farewell to the pure concept-driven euphoria, shifting instead toward a repricing based on companies' real core competitiveness and closed-loop business value. Only those enterprises capable of building strong barriers in niche markets and achieving sustainable growth will truly seize the opportunities presented by this round of capital market recovery. Recently, Maxcare Health (hereinafter referred to as "the Company") updated its prospectus, continuing to advance its listing process on the Main Board of the Hong Kong Stock Exchange. The joint sponsors are Goldman Sachs, CICC, and HSBC. This prospectus highlights the Company’s rapid revenue growth and continuous narrowing of losses, reflecting a positive trend.
Ping An Securities: Explore niche sectors benefiting from the development of commercial health insurance, and recommend attention to companies such as Maxin Health.
Gelonghui, January 27th | Ping An Securities recently released a research report titled 'Exploring Segmented Tracks Benefiting from the Development of Commercial Health Insurance,' pointing out that policy incentives support the development of health insurance, with continuous release of industry capital increment potential. Segmented tracks such as third-party administration companies (TPA) are expected to benefit. The report notes that TPAs handle core aspects like claims processing, medical service network construction, and medical expense settlements. They possess certain barriers in innovative pharmaceutical resources, insurance capabilities, actuarial pricing data empowerment, and high-quality hospital networks. It is recommended to pay attention to leading industry platforms such as Maxin Health.
Hong Kong Stock IPO Weekly Report | Multiple companies, including Jiehua Technology, filed for listing en masse; GigaDevice's debut week saw a nearly 70% surge.
According to Livermore Securities, this week (January 12th to January 18th), 24 companies submitted listing applications to the Hong Kong Stock Exchange, three companies passed the hearing, one company started its initial public offering, and four new stocks were listed.
Express News | According to documents filed with the Hong Kong Stock Exchange, Shanghai Maxure Health Technology Group Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange.
From claims acceleration to intelligent decision-making, Maxin Health has been awarded the Golden Bridge Award for Outstanding Growth Enterprise Empowered by AI.
The "2025 Investor Annual Conference and Achievement & Glory Ceremony," hosted by Thinking Finance and Investors' Network, was held in Shanghai on January 7, 2026. Under the theme of "Time as a Witness, Value in Tandem," this year's conference brought together top economists, industry leaders, and representatives from over a hundred listed companies and financial institutions to explore new industrial opportunities amid technological trends and global perspectives. At the ceremony, Medipay Health won the "Golden Bridge Award for Outstanding Growth Enterprise Empowered by AI" due to its deep integration innovation in AI technology and healthcare payment, along with remarkable growth performance. As an innovative practitioner in the field of healthcare payment, Medipay Health has consistently focused on